FDA Issues Warning on DPP-4 Inhibitors in T2D (MRK) (LLY)

August 28, 2015 12:36 PM

The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found